In Documents on Pain Drug Celebrex, Signs of Doubt and Deception

Sunday, June 24, 2012 - 22:20 in Health & Medicine

The widely used drug Celebrex was defended by Pfizer and its original maker, but doubts were played down. A long-term study of the drug is scheduled to be completed in 2014, just as its patent protection expires.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net